Total synthesis of 2-(5,6-epoxyisoprostane A2)phosphorylcholine and elucidation of the relative configuration of the isoprostane moiety

Angewandte Chemie - International Edition

Volumn 44, Issue 22, 2005, Pages 3481-3484

  Acharya, Hukum P ^a   Kobayashi, Yuichi ^a  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Aldol reaction; Isoprostanes; Phospholipids; Phosphorylcholine; Total synthesis

Indexed keywords

ACETONE; ALDEHYDES; CONDENSATION; LIPIDS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ALDOL CONDENSATION; CYCLOPENTENONE; DIASTEREOMERS; EPOXYALDEHYDES;

SYNTHESIS (CHEMICAL);

2 (5,6 EPOXYISOPROSTANE A2)PHOSPHORYLCHOLINE; 2-(5,6-EPOXYISOPROSTANE A2)PHOSPHORYLCHOLINE; DRUG DERIVATIVE; EPOXIDE; ISOPROSTANE DERIVATIVE; PHOSPHORYLCHOLINE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; STEREOISOMERISM; SYNTHESIS;

EPOXY COMPOUNDS; ISOPROSTANES; MOLECULAR CONFORMATION; MOLECULAR STRUCTURE; PHOSPHORYLCHOLINE; STEREOISOMERISM;

EID: 20444395864     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/anie.200500534     Document Type: Article

References (49)

1. A. D. Watson, G. Subbanagounder, D. S. Welsbie, K. F. Faull, M. Navab, M. E. Jung, A. M. Fogelman, J. A. Berliner, J. Biol. Chem. 1999, 274, 24787-24798.
2. a) A. D. Watson, N. Leitinger, M. Navab, K. F. Faull, S. Hörkkö, J. L. Witztum, W. Palinski, D. Schwenke, R. G. Salomon, W. Sha, G. Subbanagounder, A. M. Fogelman, J. A. Berliner, J. Biol. Chem. 1997, 272, 13597-13607;
3. b) J. A. Berliner, Vasc. Pharmacol. 2002, 38, 187-191;
4. c) A. Jerlich, R. J. Schaur, A. R. Pitt, C. M. Spickett, Free Radical Res. 2003, 37, 645-653.
5. a) N. Leitinger, T. R. Tyner, L. Oslund, C. Rizza, G. Subbanagounder, H. Lee, P. T. Shih, N. Mackman, G. Tigyi, M. C. Territo, J. A. Berliner, D. K. Vora, Proc. Natl. Acad. Sci. USA 1999, 96, 12010-12015;
6. b) J. A. Berliner, G. Subbanagounder, N. Leitinger, A. D. Watson, D. Vora, Trends Cardiovasc. Med. 2001, 11, 142-147.
7. L. Boring, J. Gosling, M. Cleary, I. F. Charo, Nature 1998, 394, 894-897.
8. G. Subbanagounder, J. W. Wong, H. Lee, K. F. Faull, E. Miller, J. L. Witztum, J. A. Berliner, J. Biol. Chem. 2002, 277, 7271-7281.
9. M. E. Jung, A. Kers, G. Subbanagounder, J. A. Berliner, Chem. Commun. 2003, 196-197. It is uncertain that the 1,4-addition of the cis-2-heptenyl anion to enone 5 would proceed at the terminal carbon atom of the anion regioselectively with retention of the cis olefin geometry.
10. For recent reviews of other isoprostane syntheses, see: a) G. Helmchen, M. Ernst, G. Paradies, Pure Appl. Chem. 2004, 76, 495-506;
11. b) L. G. Quana, J. K. Cha, Chem. Phys. Lipids 2004, 128, 3-14;
12. c) T. Durand, A. Guy, O. Henry, A. Roland, S. Bernad, S. E. Fangour, J.-P. Vidal, J.-C. Rossi, Chem. Phys. Lipids 2004, 128, 15-33;
13. d) J. Rokach, S. Kima, S. Bellone, J. A. Lawson, D. Praticò, W. S. Powell, G. A. FitzGerald, Chem. Phys. Lipids 2004, 128, 35-56;
14. e) D. F. Taber, R. S. Hoerrner, R. J. Herr, D. M. Gleave, K. Kanai, R. Pina, Q. Jiang, M. Xu, Chem. Phys. Lipids 2004, 128, 57-67.
15. a) R. Noyori, M. Suzuki, Angew. Chem. 1984, 96, 854-882;
16. Angew. Chem. Int. Ed. Engl. 1984, 23, 847-876;
17. b) R. Noyori, M. Suzuki, Chemtracts: Org. Chem. 1990, 3, 173-197;
18. c) M. Suzuki, Y. Morita, H. Koyano, M. Koga, R. Noyori, Tetrahedron 1990, 46, 4809-4822;
19. d) M. Suzuki, T. Kawagishi, A. Yanagisawa, T. Suzuki, N. Okamura, R. Noyori, Bull. Chem. Soc. Jpn. 1988, 61, 1299-1312.
20. a) T. Sugai, K. Mori, Synthesis 1988, 19-22;
21. b) K. Laumen, M. P. Schneider, J. Chem. Soc. Chem. Commun. 1986, 1298-1299.
22. H. P. Acharya, Y. Kobayashi, Tetrahedron Lett. 2004, 45, 1199-1202.
23. 3-pyridine): A. M. Kornilov, A. E. Sorochinskii, I. A. Butovich, V. P. Kukhar, Zh. Org. Khim. 1987, 23, 2470-2471;
24. A. M. Kornilov, A. E. Sorochinskii, I. A. Butovich, V. P. Kukhar, J. Org. Chem. USSR 1987, 23, 2183-2184.
25. a) G. H. Posner, G. M. Gurria, K. A. Babiak, J. Org. Chem. 1977, 42, 3173-3180;
26. b) K. Yamada, T. Arai, H. Sasai, M. Shibasaki, J. Org. Chem. 1998, 63, 3666-3672.
27. 3-assisted elimination generally produces the thermodynamically stable alkene (see reference [10] and the references cited therein).
28. a) G. L. Bundy, D. R. Morton, D. C. Peterson, E. E. Nishizawa, W. L. Miller, J. Med. Chem. 1983, 26, 790-799;
29. b) S. Sugiura, T. Toru, T. Tanaka, A. Hazato, N. Okamura, K. Bannai, K. Manabe, S. Kurozumi, R. Noyori, Chem. Pharm. Bull. 1984, 32, 4658-4661;
30. c) J. Zhu, J.-Y. Yang, A. J. H. Klunder, Z.-Y. Liu, B. Zwanenburg, Tetrahedron 1995, 51, 5847-5870.
31. 3.
32. 3 set at δ = 7.24 instead of 7.26 ppm).
33. 3) and subsequent lactonization of the resulting diol. (Chemical Equation Presented)
34. a) F. Ramirez, J. E. Marecek, Synthesis 1985, 449-488;
35. b) J. M. Delfino, S. L. Schreiber, F. M. Richards, Tetrahedron Lett. 1987, 28, 2327-2330;
36. c) J. Xia, Y.-Z. Hui, Chem. Pharm. Bull. 1999, 47, 1659-1663;
37. d) F. S. Roodsari, D. Wu, S. G. Pum, J. Hajdu, J. Org. Chem. 1999, 64, 7727-7737;
38. e) P. R. J. Gaffney, C. B. Reese, J. Chem. Soc. Perkin Trans. I 2001, 192-205.
39. For recent examples, see: a) F. M. Menger, Y.-L. Wong, J. Org. Chem. 1996, 61, 7382-7390;
40. b) J. Lindberg, J. Ekeroth, P. Konradsson, J. Org. Chem. 2002, 67, 194-199;
41. c) M. Sun, Y. Deng, E. Batyreva, W. Sha, R. G. Salomon, J. Org. Chem. 2002, 67, 3575-3584;
42. d) X. Gu, M. Sun, B. Gugiu, S. Hazen, J. W. Crabb, R. G. Salomon, J. Org. Chem. 2003, 68, 3349-3761; DCC = N,N′-cyclohexylcarbodiimide.
43. 2 to afford the product in 77% yield.
44. a) J. Inanaga, K. Hirata, H. Saeki, T. Katsuki, M. Yamaguchi, Bull. Chem. Soc. Jpn. 1979, 52, 1989-1993;
45. b) K. Makino, N. Nakajima, S. Hashimoto, O. Yonemitsu, Tetrahedron Lett. 1996, 37, 9077-9080.
46. We have used the Yamaguchi reagent for the macrocyclization of macrosphelides C, F, G, and H: a) Y. Kobayashi, H. P. Acharya, Tetrahedron Lett. 2001, 42, 2817-2820;
47. b) Y. Kobayashi, Y.-G. Wang, Tetrahedron Lett. 2002, 43, 4381-4384.
48. Because of the low solubility of the lyso-PC, toluene, the standard solvent for the Yamaguchi reaction, was not used.
49. Prepared from racemic glycidol according to a literature method; see reference [19b].